Rand Wealth’s GSK GSK Stock Holding History

Rand Wealth’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	$205K	Hold	4,080	–	–	0.02%	224
2018 Q2	$206K	Sell	4,080 -240	-6%	-$12.1K	0.02%	223
2018 Q1	$211K	Sell	4,320 -200	-4%	-$9.31K	0.02%	215
2017 Q4	$200K	Hold	4,520	–	–	0.02%	221
2017 Q3	$229K	Buy	4,520 +80	+2%	+$4.06K	0.03%	207
2017 Q2	$239K	Buy	4,440 +328	+8%	+$17.5K	0.03%	195
2017 Q1	$217K	Sell	4,112 -544	-12%	-$27.6K	0.03%	201
2016 Q4	$224K	Hold	4,656	–	–	0.03%	204
2016 Q3	$251K	Buy	4,656 +100	+2%	+$5.48K	0.03%	205
2016 Q2	$247K	Hold	4,556	–	–	0.03%	206
2016 Q1	$231K	Hold	4,556	–	–	0.03%	206
2015 Q4	$230K	Sell	4,556 -123	-3%	-$6.27K	0.03%	201
2015 Q3	$225K	Buy	4,679 +105	+2%	+$5.47K	0.03%	203
2015 Q2	$238K	Hold	4,574	–	–	0.03%	198
2015 Q1	$264K	Buy	4,574 +18	+0.4%	+$1.03K	0.04%	194
2014 Q4	$257K	Hold	4,556	–	–	0.04%	198
2014 Q3	$262K	Hold	4,556	–	–	0.04%	183
2014 Q2	$305K	Sell	4,556 -345	-7%	-$23.4K	0.04%	171
2014 Q1	$327K	Buy	4,901 +616	+14%	+$41.6K	0.06%	162
2013 Q4	$286K	Hold	4,285	–	–	0.05%	170
2013 Q3	$269K	Hold	4,285	–	–	0.05%	170
2013 Q2	$268K	Buy	+4,285	New	+$272K	0.06%	163

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Rand Wealth's GSK Position: Q3 2018 in Review

Rand Wealth held its GSK (GSK) position steady in Q3 2018 at 4,080 shares worth $205K. The position accounts for 0.02% of the portfolio, ranked #224.

Rand Wealth first reported a position in GSK in Q2 2013 and has held it in 22 quarters since. The position peaked at $327K in Q1 2014. 787 funds tracked by Wall St. Rank hold GSK as of Q3 2018.

Rand Wealth held 4,080 shares of GSK worth $205K as of Q3 2018.
Rand Wealth left its GSK share count unchanged in Q3 2018.
GSK made up 0.02% of Rand Wealth's portfolio in Q3 2018, its #224 holding.
Rand Wealth first reported a position in GSK in Q2 2013 and has held it in 22 quarters since.
Rand Wealth's GSK position peaked at $327K in Q1 2014.
787 funds tracked by Wall St. Rank held GSK as of Q3 2018.

Based on Rand Wealth's 13F filing for Q3 2018, filed 13 Nov 2018.